Vident Advisory’s QuidelOrtho QDEL Stock Holding History

Vident Advisory’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,865	Closed	-$240K	–	1688
2025 Q1	$240K	Buy	+6,865	New	+$280K	﹤0.01%	1357
2024 Q1	–	Sell	-4,191	Closed	-$309K	–	1385
2023 Q4	$309K	Buy	4,191 +1,063	+34%	+$71.9K	0.01%	987
2023 Q3	$228K	Buy	+3,128	New	+$250K	0.01%	1044

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vident Advisory's QDEL Position: Q2 2025 in Review

Vident Advisory sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 6,865 shares — an estimated $240K sold.

Vident Advisory first reported a position in QDEL in Q3 2023 and held it in 3 quarters. The position peaked at $309K in Q4 2023. 264 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.

Vident Advisory reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
Vident Advisory sold 6,865 QuidelOrtho shares in Q2 2025, an estimated $240K.
Vident Advisory first reported a position in QuidelOrtho in Q3 2023 and held it in 3 quarters.
Vident Advisory's QuidelOrtho position peaked at $309K in Q4 2023.
264 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.

Based on Vident Advisory's 13F filing for Q2 2025, filed 14 Aug 2025.